CD8A and Miyoshi myopathy: These cell markers had moderate capacity to discriminate between the ME-MM and ME-SA clinical groups in Receiver Operating Characteristic curve analyses, with an Area Under the Curve (AUC) of 0.7141 (p = 0.0007) for the CD8+T cell markers and 0.758 (p < 0.0001) for the MAITs.